Effect of Extended-Release Niacin/Laropiprant Combination on Plasma Adiponectin and Insulin Resistance in Chinese Patients with Dyslipidaemia

<div>Associations between changes in adiponectin and changes in fasting glucose (a), insulin (b), and the Homeostasis Model of Assessment-Insulin Resistance (HOMA-IR) (c) with ER niacin/laropiprant.</div>

Disease Markers

fig1

Figure 1

Figure 1: Effect of Extended-Release Niacin/Laropiprant Combination on Plasma Adiponectin and Insulin Resistance in Chinese Patients with Dyslipidaemia 

Figure 1 | Effect of Extended-Release Niacin/Laropiprant Combination on Plasma Adiponectin and Insulin Resistance in Chinese Patients with Dyslipidaemia 